Create a Report

Please provide report title
Please provide location
Please provide details

Add more

Get alerts and updates for your case!

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Skip this step

Add photos or video

We recommend photos and videos to help explain your report

Add Photo/Video
Drop files here
Skip this step

Email or SMS copy of report

Enter below to get emailed a copy of your report, or sms a link to your report

Please provide email or phone
Please provide email or phone

Thank you for your report!

The report was
successfully sent!


Your report is queued - it may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Recall notice

Phenylephrine hydrochloride Injection, USP, 10 mg/ mL recalled due to Potential Foreign Material, USA

11 months ago source fda.gov

United States

Provepharm Inc. is voluntarily recalling lot number 24020027; Expiry Date December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk Package) at the hospital/institutional level. This recall was initiated based on a customer complaint from a pharmacy after observing a visible black particulate matter found in a single-sealed vial of the product. Phenylephrine hydrochloride Injection, USP, 10 mg/ mL, was distributed nationwide in the United States to wholesalers.

Risk Statement: Administration of an injectable product containing particulate matter may cause local irritation or swelling as a response to the foreign material. If the particulate matter enters the blood vessels, it can travel to various organs and potentially blocking blood vessels in the heart, lungs or brain, leading to serious complications such as stroke or even death. To date, Provepharm Inc. has not received any reports of adverse events or injuries associated with this recall.

Phenylephrine hydrochloride Injection is used for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia and is packaged in 10 mL vial, 1 single dose vial, with NDC code as 81284-213-01. The product can be identified by product name on carton and vial label and with lot number 24020027 and Exp. Date: Dec 2025 (NDC 81284-213-01) (See label below).

Provepharm Inc., in collaboration with its recall provider, Sedgwick, is notifying distributors and customers via UPS Ground and coordinating the return of all recalled products. Wholesalers, distributors, compounding companies and hospitals in procession of the recalled Phenylephrine hydrochloride Injection, USP, 10 mg/ mL lot number 24020027, Exp date December 2025, should immediately cease use of and return the product to Sedgwick at the following address Sedgwick  Event## 8664  2670 Executive Drive, Suite A  Indianapolis, IN 46241

Customers with questions regarding this recall can contact from 8:00 am to 5:00 pm (EST) Monday - Friday at:
Product Returns: Contact Sedgwick at: IVR: 866-737-5394 FAX: 866-250-4503
Medical-related Questions Contact Medical Information at: 1-833-727-6556

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Company name: Provepharm Inc.
Brand name: Provepharm Inc.
Product recalled: Phenylephrine hydrochloride Injection, USP, 10 mg/ mL
Reason of the recall: Device & Drug Safety – Potential Foreign Material
FDA Recall date: January 24, 2025

Source: www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/provepharm-inc-issues-voluntary-nationwide-recall-one-lot-phenylephrine-hydrochloride-injection-usp

#drugs #recall #unitedstates

Recent Reports Near Me